NBIX
Neurocrine Biosciences Inc
$155.50
+0.54% (+$0.83)
Volume
1.04M
52W High
$162.39
52W Low
$117.59
Market Cap
$13.60B
Next Earnings Report
Last Reported
May 6, 2026 Beat
Actual: $1.94
vs. Consensus: $1.11
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 6, 2026
1-Day:
+1.75%
5-Day:
+2.43%
Q1 2026
May 5, 2026
1-Day:
+8.86%
Q1 2026
May 4, 2026
1-Day:
+0.74%
Q4 2025
Feb 11, 2026
1-Day:
-10.43%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $805.5M | +28.3% | 97.8% | 26.2% | $153.7M |
| Q3'25 | $794.9M | +27.8% | 98.2% | 30.1% | $209.5M |
| Q2'25 | $687.5M | +16.5% | 98.4% | 21.2% | $107.5M |
| Q1'25 | $572.6M | +11.1% | 98.4% | 4.1% | $7.9M |
| Q4'24 | $627.7M | +21.8% | 98.5% | 22.6% | $103.1M |
| Q3'24 | $622.1M | +24.7% | 98.7% | 29.6% | $129.8M |
| Q2'24 | $590.2M | +30.4% | 98.4% | 24.6% | $65.0M |
| Q1'24 | $515.3M | +22.6% | 98.5% | 19.3% | $43.4M |
Company Information
Symbol
NBIX
Company
Neurocrine Biosciences Inc
Market Cap
$13.60B